In Melasma Melasma is a common skin problem that causes dark, discolored patches on your skin primarily on the face. It frequently occurs during pregnancy and menopause. Gluone Forte Tablet helps to lighten these dark patches on the skin by reducing the production of melanin (natural skin pigment). Gluone Forte Tablet also lightens skin color and makes it smooth. This helps boost your self-esteem and confidence as your appearance changes. Keep using it for as long as it is prescribed to get the full benefits. In Hyperpigmentation Hyperpigmentation occurs when your skin produces more melanin, the pigment that gives your skin its color. This can make spots or patches of skin appear darker than surrounding areas. Gluone Forte Tablet reduces the dark spots or patches by lowering melanin production in the body. It also lightens skin tone and helps restore the normal color of the skin. It also helps to protect the skin from damage by ultraviolet rays of the sun and prevents sunburns. Taking Gluone Forte Tablet boosts your self-esteem and confidence as your skin texture improves.
Caution is advised when consuming alcohol with Gluone Forte Tablet. Please consult your doctor.
Information regarding the use of Gluone Forte Tablet during pregnancy is not available. Please consult your doctor.
Gluone Forte Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Gluone Forte Tablet does not usually affect your ability to drive.
There is limited information available on the use of Gluone Forte Tablet in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Gluone Forte Tablet in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Senechio Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Senechio Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nexgen Rx Life Science Pvt Ltd || ₹14.5/tablet (25% cheaper)